The Functional Assessment of Cancer Therapy-BRM (FACT-BRM): A New Tool for the Assessment of Quality of Life in Patients Treated with Biologic Response ModifiersJ. Bacik, M. Mazumdar, B. A. Murphy, D. L. Fairclough, S. Eremenco, T. Mariani, R. J. Motzer and D. Cella · Quality of Life Research · 2004

Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell TumorsR. J. Motzer; M. Mazumdar; S. C. Gulati; D. F. Bajorin; P. Lyn; V. Vlamis; G. J. Bosl · 1993